Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of mGluR5 antagonists for the treatment of gerd

Use of mGluR5 antagonists for the treatment of gerd

US Patent 7964609 · Granted Jun 21, 2011

Estimated economic value: $4,946,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibito2025
Benzothiadiazepine compounds and their use as bile acid modulators2025
Benzothiazepine compounds and their use as bile acid modulators2023
Benzothiadiazepine compounds and their use as bile acid modulators2023
Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibito2023
Benzothia(di)azepine compounds and their use as bile acid modulators2022
Benzothiazepine compounds and their use as bile acid modulators2021
Benzothiadiazepine compounds and their use as bile acid modulators2021
Benzothia(di)azepine compounds and their use as bile acid modulators2020
Use of GabaB receptor agonists2010
Imidazole variants as modulators of GABA receptor for the treatment of GI disord2010
Additional heteropolycyclic compounds and their use as metabotropic glutamate re2009